APA (7th ed.) Citation

Kasurinen, A., Laitinen, A., Kokkola, A., Stenman, U., Böckelman, C., & Haglund, C. (2020). Tumor-associated trypsin inhibitor (TATI) and tumor-associated trypsin-2 (TAT-2) predict outcomes in gastric cancer. Acta Oncologica, 59(6), 681. https://doi.org/10.1080/0284186X.2020.1733655

Chicago Style (17th ed.) Citation

Kasurinen, Aaro, Alli Laitinen, Arto Kokkola, Ulf-Håkan Stenman, Camilla Böckelman, and Caj Haglund. "Tumor-associated Trypsin Inhibitor (TATI) and Tumor-associated Trypsin-2 (TAT-2) Predict Outcomes in Gastric Cancer." Acta Oncologica 59, no. 6 (2020): 681. https://doi.org/10.1080/0284186X.2020.1733655.

MLA (9th ed.) Citation

Kasurinen, Aaro, et al. "Tumor-associated Trypsin Inhibitor (TATI) and Tumor-associated Trypsin-2 (TAT-2) Predict Outcomes in Gastric Cancer." Acta Oncologica, vol. 59, no. 6, 2020, p. 681, https://doi.org/10.1080/0284186X.2020.1733655.